“Safety and tolerability of a single dose T0001 in Chinese healthy adult volunteers: a first-in-human ascending dose study” (2020) Brazilian Journal of Pharmaceutical Sciences, 56, p. e18447. doi:10.1590/s2175-97902019000418447.